|
InterAgency Board (IAB)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, ATSDR
|
NIEHS
|
Sanctioned by the Attorney General of the United States, the InterAgency Board for Equipment Standardization and Interoperability (IAB) was founded by the Department of Defense's Consequence Management Program Integration Office and the Department of Justice's Federal Bureau of Investigation Weapons of Mass Destruction Countermeasures on October 13, 1998. The IAB is a voluntary collaborative panel of emergency preparedness and response practitioners from a wide
array of professional disciplines that represent all levels of government and the voluntary sector. The IAB
provides a structured forum for the exchange of ideas among operational, technical, and support
organizations to improve national preparedness and promote interoperability and compatibility among local,
state, and federal response communities. Based on direct field experience, IAB members advocate for and
assist the development and implementation of performance criteria, standards, test protocols, and technical,
operating, and training requirements for all-hazards incident response equipment with a special emphasis on
Chemical, Biological, Radiological, Nuclear, and Explosive issues. The IAB also informs broader emergency
preparedness and response policy, doctrine, and practice.
|
|
Interagency Cancer Diagnostic Devises Task Force for Near-Patient Use (CD2)
|
Committee, Work group, Advisory group, or Task Force
|
CMS, FDA, HRSA
|
NCI
|
The NCI, FDA, Health Resources and Services Administration (HRSA) and CMS partnered in late 2019 to establish the Interagency Cancer Diagnostic Devices (CD2) Task Force for Near-Patient Use. Near-patient diagnostics generally refers to a system whereby a sample is analyzed, and the results are delivered in the same location and while the patient is being evaluated. Near-patient diagnostics are often offered at point-of-care settings where at-home tests may be available with a prescription or purchased over-the-counter. CD2 is a collaborative effort among four federal partners working together within and across their respective missions to bring more solutions to: detect and diagnose cancer earlier; enhance identification of patients at high risk of developing cancer and surveillance of those at risk of cancer recurrence; improve monitoring of patient response during cancer treatment; and reduce the effect of health disparities and equitably extend the benefits of health care to all populations. The primary goal of this initiative is to develop opportunities that accelerate the pace by which point of care diagnostic devices get to patients for the earlier detection and screening of cancer. The Task Force and Initiative will address cancer types for geographically isolated, medically underserved, and otherwise vulnerable communities, with emphasis to: 1) Cancer types with clear, existing need and highly prevalent, for example cervical cancer; and 2) Cancer types that have evidence of future need from emerging at-risk populations, for example liver cancers derived from nonalcoholic steatohepatitis (NASH).
|
|
Interagency Chemical Risk Assessment Working Group
|
Committee, Work group, Advisory group, or Task Force
|
OS
|
NINDS, NIAID
|
This working group is a Department of Homeland Security led effort to determine chemical hazards and develop Chemical Risk Threat Assessment list of priority chemicals.
|
|
Interagency Collaborative Animal Research Education (ICARE) Training Project
|
Training Initiative
|
CDC, FDA, ASPR
|
OD/OER
|
The Interagency Collaborative Animal Research Education (ICARE) Academies and Train the Trainer Institutes use active learning to train participants to meet their responsibilities for animal welfare oversight. The program empowers accountability for facts and conceptual understanding of Federal standards through the study of realistic problems encountered in animal care and use programs. Faculty includes subject matter experts from biomedical research institutions and federal agencies, including National Institutes of Health (NIH) and United States Department of Agriculture (USDA). Institutional Animal Care and Use Committee members, staff, institutional officials, veterinarians, animal facility personnel, administrators, consultants, as well as compliance and regulatory personnel involved in the humane use of animals in research all may participate in the ICARE program.
|
|
Interagency Collaborative to Advance Research in Epilepsy (ICARE)
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, FDA, HRSA, OS
|
NINDS, FIC, NCATS, NHGRI, NHLBI, NIA, NIAAA, NIAMS, NICHD, NIDA, NIMH
|
The Interagency Collaborative to Advance Research in Epilepsy (ICARE) is an interagency epilepsy working group that includes broad representation across the National Institutes of Health (NIH) institutes and centers (ICs) involved in epilepsy-related research, as well as across the Department of Health and Human Services other Federal agencies multiple epilepsy research organizations, and patient advocacy groups with a primary focus on biomedical research. The purpose of this group, which is led by the National Institute of Neurological Disorders and Stroke, is to increase communication among institutes and agencies sponsoring epilepsy-related research and to explore opportunities for increased coordination. The group’s annual meetings provide a forum for sharing information about ongoing and planned epilepsy research activities, highlighting advances, discussing needs and opportunities, and promoting increased collaboration toward common research goals.
|
|
Interagency Committee on Disability Research (ICDR)
|
Committee, Work group, Advisory group, or Task Force
|
ACF, ACL, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, IHS, OS, Office of the Surgeon General (OSC), SAMHSA
|
NICHD, NIDCD, NIMH, NINDS
|
The ICDR's mission is to promote coordination and cooperation among federal departments and agencies conducting disability, independent living, and rehabilitation research programs including programs relating to assistive technology research and research that incorporates the principles of universal design.
|
|
Interagency Committee on Human Nutrition Research (ICHNR)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, HRSA, OASH, Other
|
OD/DPCPSI/ONR, NCI, OD/DPCPSI/ODS, NICHD
|
The Interagency Committee on Human Nutrition Research (ICHRN) is charged with improving the planning, coordination, and communication among federal agencies engaged in nutrition research and with facilitating the development and updating of plans for federal research programs to meet current and future domestic and international needs for nutrition.
|
|
Interagency Committee on Smoking and Health
|
Committee, Work group, Advisory group, or Task Force
|
CDC, CMS, FDA, HRSA, SAMHSA
|
NIDA, NCI
|
The Committee was chartered in 1985 and advises the Secretary, Department of Health and Human Services (DHHS), the Assistant Secretary for Health, and the Centers for Disease Control and Prevention on coordination of research, educational programs, and other activities within the Department that relate to the effect of smoking on human health, and on coordination of these activities with other Federal, State, local, and private agencies. The Committee established and maintains a liaison with appropriate private entities, other Federal agencies, and State and local public agencies respecting activities relating to the effect of cigarette smoking on human health.
|
|
Interagency Committee on the American Community Survey (ACS)
|
Committee, Work group, Advisory group, or Task Force
|
ACF, AHRQ, CDC, CMS, HRSA, OS
|
NICHD
|
The American Community Survey (ACS) is an ongoing survey that provides vital information on a yearly basis about our nation and its people. Information from the survey generates data that help determine how more than $400 billion in federal and state funds are distributed each year. Public officials, planners, and entrepreneurs use this information to assess the past and plan the future.
|
|
Interagency Comparative Genomics Interest Group
|
Meeting/ Workshop
|
CDC
|
NHGRI
|
Meets quarterly to discuss advances, funding opportunities, and potential points of collaboration across agencies in comparative genomics.
|